![](/media/5873/181211-anh_pressrelease.jpg?mode=max&width=720&rnd=131890139450000000)
Personalised medicine offers new hope for pancreatic cancer patients
The diagnosis of pancreatic cancer is widely regarded as a death sentence. A paper just published in the peer-reviewed journal Integrative Molecular Medicine suggests that a more personalised approach taking into account an individual’s genetic background might offer more hope for those who develop pancreatic cancer in the future.